A significant shift in the European technology landscape is underway, marked by the return of top-tier talent from competitive American tech hubs to tackle some of the continent’s most entrenched problems. Berlin-based health-tech firm aiomics is at the forefront of this movement, recently completing its leadership team by appointing former Salesforce Creative Director Oliver Stubel as its new Head of Product. This strategic hire is more than just a personnel change; it represents the culmination of a deliberate strategy to assemble a unique coalition of experts from disparate, highly specialized fields. The company’s mission is to resolve the deep-seated crisis of unstructured data that plagues modern healthcare, a problem that drains resources, burns out clinicians, and ultimately compromises patient care. By fusing advanced engineering with an intense focus on user experience, this team aims to humanize medical technology and restore the focus of healthcare to the patient.
A Crisis of Data and a New Mandate for Design
The fundamental challenge aiomics was established to overcome is the pervasive issue of “data solvency” within healthcare systems, a crisis created by the sheer volume of unstructured and low-quality clinical documentation. This “data debris,” composed of inconsistent notes, raw patient chart entries, and varied reports, forms a digital quagmire that creates an immense administrative burden on medical professionals. Clinicians, who have undergone years of rigorous training to care for patients, are instead forced to dedicate countless hours to navigating clunky software and performing data entry, a diversion of expertise that contributes directly to widespread burnout and decreased job satisfaction. The consequences ripple beyond the well-being of staff, posing a direct financial threat to hospitals. Incomplete or improperly formatted documentation frequently leads to non-compliance with complex payer regulations, resulting in costly insurance clawbacks that can severely jeopardize the financial stability of healthcare institutions. This systemic inefficiency not only drains resources but also erodes the core function of the healthcare system: delivering effective patient care.
In response to this multifaceted crisis, aiomics has engineered a sophisticated, two-pronged approach designed not only to stabilize hospital finances but also to fundamentally improve clinical workflows. The first and most immediate function of its technology is to secure “revenue integrity” by transforming chaotic, unstructured data into compliant and actionable intelligence that satisfies the rigorous documentation standards required by insurers and regulators. However, the company’s leadership articulates a mission that extends well beyond serving as mere “financial plumbing.” The deeper, more transformative goal is to achieve holistic system resilience by empowering the interdisciplinary care team. This involves removing the significant “cognitive load of data management” from clinicians. The strategic appointment of Oliver Stubel is pivotal to this second objective. His mandate is to infuse a powerful backend engine with a “Silicon Valley-style” customer-centric design, ensuring the front-end interface is intuitive and frictionless, thereby allowing doctors, nurses, and therapists to focus their attention on the patient rather than the computer screen.
A Coalition of Hard Disciplines
The Founding Trio Medicine Physics and Law
At the heart of the aiomics strategy is a leadership team intentionally constructed from experts in distinct and demanding fields, a stark contrast to the typical startup founder profile. This coalition is anchored by CEO Dr. Sven Jungmann, the Clinician, who provides an essential and authentic link between the company’s executive strategy and the stark realities of clinical practice. Having spent years on the front lines in emergency rooms and oncology wards, Dr. Jungmann possesses an intimate, firsthand understanding of the daily pressures, workflow inefficiencies, and administrative frustrations faced by medical staff. This practical knowledge is powerfully combined with extensive business acumen, which he developed as Chief Medical Officer at Helios’ digital arm and as a Partner at a corporate venture builder. His dual perspective ensures that the company’s technological solutions are not developed in a vacuum but are meticulously grounded in the real-world, high-stakes needs of healthcare providers, addressing the pain points that he himself has experienced. This prevents the common pitfall of creating technology that, while powerful, is misaligned with clinical reality.
Complementing this clinical expertise is a foundation of formidable technical and regulatory rigor, supplied by the other two co-founders. CTO Dr. Nikita Tarasov, the Physicist, brings the precision and analytical discipline of the hard sciences to the company’s technological core. As a data scientist with a PhD in physics and a background in the algorithmic analysis of EKG data, he approaches the complexities of clinical information with scientific exactitude. Critically, his previous role leading the development of cloud-native data infrastructures in the highly regulated financial sector enables him to architect the aiomics platform with bank-level security and compliance standards—a non-negotiable requirement for handling sensitive patient data. Rounding out this trio is COO Kirill Schitomirski, the Lawyer. As a fully accredited German lawyer, Schitomirski provides the crucial legal expertise required to navigate the intricate “minefield” of healthcare regulations. He ensures that the company’s AI-driven solutions are designed from the ground up to help hospitals satisfy complex payer rules, thereby mitigating financial risk. This legal acumen is paired with high-velocity operational experience gained as an early employee at a hospitality unicorn, equipping him to drive the company’s rapid scaling while maintaining strict compliance.
The Final Piece Human-Centric Design
The recent recruitment of Oliver Stubel as Head of Product represents the final, crucial piece of this interdisciplinary leadership puzzle, designed to bridge the gap between powerful backend technology and the end-user. His arrival is a prominent example of a “reverse brain drain,” a trend where elite talent, after gaining invaluable experience in hyper-competitive U.S. tech hubs, returns to enrich the European technology ecosystem. Stubel, a Hamburg native, brings back years of experience as a Creative Director at Salesforce, where he led design engagements with major U.S. hospital systems. His primary mandate is to inject a deep sense of customer centricity into the product, directly confronting a well-known weakness in European clinical software, which is often criticized for being counter-intuitive and “click-intensive.” His expertise is not merely aesthetic; it is about fundamentally re-engineering the human-computer interaction in a clinical setting to reduce friction, save time, and prevent the user frustration that plagues existing systems. He is tasked with making the technology disappear into the workflow.
A Synthesized Vision for a More Human System
The assembly of this unique leadership team operationalized a clear and unified strategic vision: to fuse technical power, regulatory precision, and human-centric design in service of a single goal. The mission was to clear the “administrative debris” that so often obstructs the vital relationship between a caregiver and a patient. By creating a product that felt intuitive and supportive rather than obstructive, aiomics ensured its technology could facilitate a truly collaborative environment. This approach was designed to empower doctors, nurses, and patients to engage in shared decision-making “at eye level,” free from the distraction of cumbersome software. The synthesis of Dr. Jungmann’s clinical insight, Dr. Tarasov’s scientific rigor, Schitomirski’s legal acumen, and Stubel’s user-focused design positioned the company to create a more sustainable, resilient, and ultimately more human healthcare system. With this complete team in place, the company began deploying its solutions across the DACH region, relying on evidence-based validation to prove its impact.
